TITLE

Mesalazine

PUB. DATE
August 2013
SOURCE
Reactions Weekly;8/10/2013, Issue 1465, p27
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
An abstract of the article "Mesalamine-induced transaminitis; a rare presentation.," by R. Shah and colleagues is presented.
ACCESSION #
89728794

 

Related Articles

  • Desflurane/sevoflurane.  // Reactions Weekly;8/13/2011, Issue 1364, p17 

    The article describes the case of a man who developed ulcerative colitis after receiving desflurane and sevoflurane.

  • Mesalazine.  // Reactions Weekly;1/9/2010 Part 2 of 2, Issue 1283, p64 

    The article describes a case of exacerbation of ulcerative colitis in a 30-year-old woman following treatment with a mesalazine enema.

  • Sulphaalazine desenitisation.  // British Medical Journal (Clinical Research Edition);1/10/1981, Vol. 282 Issue 6258, p110 

    Focuses on the desensitization of sulfasalazine in the treatment of diseases in Great Britain. Value of the drug for the treatment of ulcerative colitis; Adverse reactions of the drugs to patients; Consideration of desensitization as an easy outpatient procedure; Use of the drug for maintenance...

  • Mercaptopurine.  // Reactions Weekly;1/5/2013, Issue 1433, p30 

    The article describes the cases of three patients who developed hepatotoxicity while receiving mercaptopurine for either ulcerative colitis or Crohn's disease.

  • Mercaptopurine.  // Reactions Weekly;8/11/2012, Issue 1414, p34 

    The article describes the case of a 56-year-old woman who developed pulmonary lymphomatoid granulomatosis (PLG) during treatment with mercaptopurine for ulcerative colitis.

  • Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial. Palmer, K.R.; Goepel, J.R.; Holdsworth, C.D. // British Medical Journal (Clinical Research Edition);5/16/1981, Vol. 282 Issue 6276, p1571 

    Examines the therapeutic role of sulphasalazine retention enemas in ulcerative colitis in Great Britain. Assessment of benefit and side effects of the drug; Efficacy of rectal sulphasalazine in both severe and mild disease; Therapeutic action of the drug within the colon.

  • Corticosteroids/infliximab/Lactobacillus rhamnosus.  // Reactions Weekly;5/11/2013, Issue 1452, p14 

    The article presents a case study of a 17-year-old ulcerative colitis male patient who developed Lactobacillus bacteraemia after receiving treatment with a probiotic containing Lactobacillus rhamnosus and immunosuppressive therapy with methylprednisolone, infliximab, and prednisone.

  • Mesalazine.  // Reactions Weekly;5/11/2013, Issue 1452, p28 

    The article presents a case study of a 22-year-old male with acute myocarditis, which developed while being treated with mesalazine for ulcerative colitis.

  • Rituximab.  // Reactions Weekly;5/11/2013, Issue 1452, p37 

    The article presents a case study of a 38-year-old woman with ulcerative colitis, which developed while receiving rituximab for seronegative rheumatoid arthritis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics